Genome-wide shRNA screen revealed integrated mitogenic signaling between dopamine receptor D2 (DRD2) and epidermal growth factor receptor (EGFR) in glioblastoma-Reference-Cited by-同舟云学术

Genome-wide shRNA screen revealed integrated mitogenic signaling between dopamine receptor D2 (DRD2) and epidermal growth factor receptor (EGFR) in glioblastoma

Published:2014-02-28 Issue:4 Volume:5 Page:882-893
ISSN:1949-2553
Container-title:Oncotarget
language:en
Short-container-title:Oncotarget

Author:

Li Jie¹,Zhu Shan²,Kozono David²,Ng Kimberly¹,Futalan Diahnn¹,Shen Ying¹,Akers Johnny C.¹,Steed Tyler¹,Kushwaha Deepa²,Schlabach Michael³,Carter Bob S.¹,Kwon Chang-Hyuk⁴,Furnari Frank⁵,Cavenee Webster⁵,Elledge Stephen⁶,Chen Clark C.¹

Affiliation:

1. Center for Translational and Applied Neuro-oncology, Division of Neurosurgery, University of California, San Diego, CA

2. Department of Radiation Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA

3. Novartis Institutes for BioMedical Research, Cambridge, MA

4. Department of Neurological Surgery and Solid Tumor Program, Ohio State University Medical Center, Columbus, OH

5. Ludwig Institute for Cancer Research, La Jolla, CA

6. Department of Genetics, Harvard Medical School, Boston, MA

Publisher

Impact Journals, LLC

Subject

Oncology

Cited by 114 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Widespread Neuroanatomical Integration and Distinct Electrophysiological Properties of Glioma-Innervating Neurons;2024-08-26

2. Therapeutic strategies for colorectal cancer: antitumor efficacy of dopamine D2 receptor antagonists;Toxicological Research;2024-08-07

3. ONC201 (Dordaviprone) in Recurrent H3 K27M–Mutant Diffuse Midline Glioma;Journal of Clinical Oncology;2024-05-01

4. Imipridones and Dopamine Receptor Antagonism in the Therapeutic Management of Gliomas;Advances in Oncology;2024-05

5. DRD1 suppresses cell proliferation and reduces EGFR activation and PD‐L1 expression in NSCLC;Molecular Oncology;2024-04-04